Seners Pierre, Ter Schiphorst Adrien, Wouters Anke, Yuen Nicole, Mlynash Michael, Arquizan Caroline, Heit Jeremy J, Sablot Denis, Wacongne Anne, Lalu Thibault, Costalat Vincent, Albers Gregory W, Lansberg Maarten G
Neurology Department, Hôpital Fondation A. de Rothschild, Paris, France.
Université Paris Cité, Institute of Psychiatrie and Neurosciences of Paris (IPNP), INSERM U1266, Team Turc, Paris, France.
Eur Stroke J. 2025 Jun 26:23969873251349713. doi: 10.1177/23969873251349713.
Patients with acute ischemic stroke with a large vessel occlusion (AIS-LVO) admitted to primary stroke centers (PSC) often require inter-hospital transfer to a comprehensive stroke center (CSC) for endovascular therapy (EVT). We aimed to determine the incidence of hemorrhagic transformation (HT) occurring during transfer, the factors associated with HT, and its relationship with 3-month outcome.
We retrospectively analyzed data from two cohorts of AIS-LVO patients transferred from a PSC to a CSC for consideration of EVT. Patients were included if they had evidence of an anterior circulation AIS-LVO at the PSC and had a standard-of-care control brain imaging upon CSC arrival. HT was defined as any new hemorrhagic lesion within brain parenchyma visible on CSC admission imaging. Among HT patients, HT expansion was defined as an absolute volume increase of ⩾6 mL and a relative growth of ⩾33% between admission imaging and 24-h follow-up.
Overall, 566 patients were included, of whom 31 (5.5%) experienced HT during transfer. Inter-hospital HT was independently associated with inter-hospital arterial recanalization (adjusted odds ratio (aOR) = 6.95, 95%CI 2.94-16.39), higher pre-transfer NIHSS score (aOR = 1.08, 95%CI 1.02-1.14), and longer time from symptom onset to CSC arrival (aOR = 1.09, 95%CI 1.04-1.13). HT expansion between CSC arrival and 24 h occurred in 24% of HT cases. Inter-hospital HT was independently associated with modified Rankin scale ⩾3 at 3-month (aOR = 3.54, 95%CI 1.08-11.67, = 0.038).
HT during inter-hospital transfer for EVT is an uncommon event, yet is associated with a high rate of subsequent expansion and poor 3-month functional outcome. Treatments to reduce HT risk may be considered.
入住初级卒中中心(PSC)的急性缺血性卒中伴大血管闭塞(AIS-LVO)患者通常需要院间转运至综合卒中中心(CSC)进行血管内治疗(EVT)。我们旨在确定转运期间发生出血性转化(HT)的发生率、与HT相关的因素及其与3个月预后的关系。
我们回顾性分析了两组从PSC转运至CSC以考虑进行EVT的AIS-LVO患者的数据。如果患者在PSC有前循环AIS-LVO的证据且在抵达CSC时进行了标准护理对照脑成像,则纳入研究。HT定义为CSC入院成像上可见的脑实质内任何新的出血性病变。在HT患者中,HT扩展定义为入院成像与24小时随访之间绝对体积增加≥6 mL且相对增长≥33%。
总体而言,纳入了566例患者,其中31例(5.5%)在转运期间发生了HT。院间HT与院间动脉再通独立相关(调整后的优势比(aOR)=6.95,95%置信区间2.94-16.39)、转运前较高的美国国立卫生研究院卒中量表(NIHSS)评分(aOR=1.08,95%置信区间1.02-1.14)以及从症状发作到抵达CSC的时间较长(aOR=1.09,95%置信区间1.04-1.13)。24%的HT病例在CSC抵达后24小时内发生了HT扩展。院间HT与3个月时改良Rankin量表评分≥3独立相关(aOR=3.54,95%置信区间1.08-11.67,P=0.038)。
EVT院间转运期间的HT是一种罕见事件,但与随后的高扩展率和3个月时不良的功能预后相关。可考虑采取降低HT风险的治疗措施。